| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |